Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple

Ying Chen1,2, Jinjun Qian2, Pinggang Ding2

  • 1Nanjing Hospital of Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Nanjing, China.

Cell Death & Disease
|September 26, 2022
PubMed

Insights

Human sideroflexin 2 (SFXN2) is elevated in multiple myeloma (MM) and promotes cancer cell growth by disrupting mitochondrial iron metabolism and autophagy. Inhibiting SFXN2 shows therapeutic potential for MM treatment.

Area of Science:

  • Mitochondrial biology
  • Cancer metabolism
  • Hematology

Background:

  • Mitochondrial outer membrane protein sideroflexin 2 (SFXN2) plays a role in mitochondrial iron metabolism.
  • The precise function of SFXN2 in multiple myeloma (MM) and its impact on mitochondrial homeostasis remain unclear.

Purpose of the Study:

  • To investigate the role of SFXN2 in the pathogenesis of multiple myeloma.
  • To explore the potential of SFXN2 as a therapeutic target in MM.

Main Methods:

  • Analysis of clinical datasets to correlate SFXN2 levels with MM patient outcomes.
  • In vitro studies using MM cell lines (ARP1, H929) to assess the effects of SFXN2 overexpression and knockdown on cell proliferation, autophagy, and mitophagy.
  • In vivo studies using a myeloma xenograft model to evaluate the anti-myeloma activity of SFXN2 inhibition.
  • Mechanistic studies to elucidate the involvement of heme oxygenase 1 (HO1) in SFXN2-mediated processes.

Main Results:

  • SFXN2 expression is significantly elevated in MM patients and correlates with poor prognosis.
  • SFXN2 overexpression enhances MM cell proliferation and suppresses starvation-induced autophagy/mitophagy.
  • SFXN2 knockdown exacerbates mitochondrial damage and enhances autophagic processes in MM cells.
  • Inhibition of SFXN2 demonstrates significant anti-myeloma activity in vivo.
  • Heme oxygenase 1 (HO1) contributes to SFXN2-mediated autophagy suppression and proliferation.

Conclusions:

  • SFXN2 is a critical regulator of mitochondrial bioenergetics, mitophagy, iron metabolism, and redox homeostasis in MM.
  • SFXN2 plays a significant role in MM cell proliferation and survival.
  • Targeting SFXN2, potentially in conjunction with iron metabolism modulation, offers a promising therapeutic strategy for MM.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.2K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.9K